Tandem Diabetes Care (TNDM)

$26.57 0.00 (0.00%)

16:00 EDT TNDM Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Nov 3, 2022

We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!

5 Top Stock Trades for Friday: SIG, MSFT, TNDM

8 Stocks to Buy That Are Growing Faster Than Amazon

10 Cheap Stocks to Buy Now

More Articles

Volume:

Previous Close -

Market Cap 1.67B

PE Ratio -8.38

EPS -3.17

Volume (Avg. Vol.)

Day's Range -

52-Week Range $26.11 - $75.47

Dividend & Yield N/A (N/A)

TNDM Stock Predictions, Articles, and Tandem Diabetes Care News

From InvestorPlace
From the Web

Why Tandem Diabetes Stock Will Rally Much Further

By Chris Lau, InvestorPlace Contributor Apr 5, 2019

Tandem reported solid Q4 numbers, and TNDM stock has multiple, other potential positive catalysts.

5 Top Stock Trades for Tuesday: BAC, NFLX, ATVI, INTC

By Bret Kenwell, InvestorPlace Contributor Apr 1, 2019

Tandem Diabetes, Netflix, Activision Blizzard, Intel and Bank of America are our top stock trades to watch going into Tuesday.

Wait for the Inevitable Pullback to Buy TNDM Stock

By Will Healy, InvestorPlace Contributor Feb 28, 2019

TNDM stock should enjoy a bright, long-term future, but the quick run-up could mean Tandem Diabetes Care stock sees a near-term pullback.

5 Healthcare Stocks to Buy for Complete Portfolio Wellness

By Josh Enomoto, InvestorPlace Contributor Oct 10, 2018

Thanks to advancing technologies and a generally positive economy, healthcare stocks are back in the limelight.

Tandem Diabetes Is Firing on All Cylinders

By Chris Lau, InvestorPlace Contributor Sep 11, 2018

Tandem Diabetes sold shares of TNDM stock, but Tandem Diabetes stock continued to rocket higher. TNDM's Q2 results impressed investors, but its seasonally strong Q4 earnings could wow them more.

Why Tandem Stock Could Continue Its Rally

By Chris Lau, InvestorPlace Contributor Jun 25, 2018

Tandem stock rocketed to a new high after the company won an FDA approval and two analyst upgrades. At a one billion dollar market cap, the stock still has upside.

Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet

By Chris Lau, InvestorPlace Contributor Apr 13, 2018

Tandem Diabetes is firing on all cylinders and markets are already noticing. TNDM has more growth ahead than is currently priced into the stock.

4 Top Growth Picks as MedTech Battle Rages On

By Zacks Investment Research Oct 16, 2017

Trump’s Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.

Insulet stock falls as Medtronic to buy insulin pump maker

From Seeking Alpha May 25, 2023

Insulet Corporation (PODD) and Tandem Diabetes (TNDM) traded lower Thursday after Medtronic (MDT) agreed to buy a Korean maker of insulin pumps. Read more here.

2 Beaten-Down Growth Stocks to Buy in April

From The Motley Fool Apr 20, 2023

These companies have lucrative opportunities ahead.

Baxter stock Tandem stock are Barclays’ bullish high-conviction calls

From Seeking Alpha Apr 11, 2023

Barclays grouped Baxter (BAX), Edwards Lifesciences (EW), Tandem Diabetes (TNDM), and Globus Medical (GMED) as its bullish high conviction calls in MedTech. Read more here.

Why did Tandem Diabetes Care stock go down today? Medtronic downgrade (NASDAQ:TNDM)

From Seeking Alpha Mar 29, 2023

Shares of Tandem Diabetes Care (TNDM) dropped for the third straight session on Wednesday after UBS downgraded rival insulin pump maker Medtronic (MDT). Read more here.

This Stock Could Soar By as Much as 106%, According to Wall Street

From The Motley Fool Mar 5, 2023

Some of Wall Street's predictions seem a bit aggressive, but investors should still consider this company.

2 Growth Stocks to Buy While They Are Still Down

From The Motley Fool Jan 27, 2023

Don't wait too long before loading up on these stocks.